ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Quantifying Contact Patterns: Development and Characteristics of the British Columbia COVID-19 Population Mixing Patterns Survey
This article has 16 authors:Reviewed by ScreenIT
-
Cryptic Transmission of the Delta Variant AY.3 Sublineage of SARS-CoV-2 among Fully Vaccinated Patients on an Inpatient Ward
This article has 4 authors:Reviewed by ScreenIT
-
Data analysis of COVID-19 wave peaks in relation to latitude and temperature for multiple nations
This article has 3 authors:Reviewed by ScreenIT
-
A Novel Convolutional Neural Network for COVID-19 detection and classification using Chest X-Ray images
This article has 6 authors:Reviewed by ScreenIT
-
A systematic comparison of novel and existing differential analysis methods for CyTOF data
This article has 8 authors:Reviewed by ScreenIT
-
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers
This article has 34 authors:Reviewed by ScreenIT
-
Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19
This article has 34 authors:Reviewed by ScreenIT
-
Multiplexed detection of SARS-CoV-2 genomic and subgenomic RNA using in situ hybridization
This article has 15 authors:Reviewed by ScreenIT
-
Non-Woven Infection Prevention Fabrics Coated with Biobased Cranberry Extracts Inactivate Enveloped Viruses Such as SARS-CoV-2 and Multidrug-Resistant Bacteria
This article has 9 authors:Reviewed by ScreenIT
-
A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
This article has 14 authors:Reviewed by ScreenIT